Advancing Synovial Sarcoma Care: Exploring Innovations in Targeted Therapies - Episode 2

Addressing Unmet Needs in Synovial Sarcoma and Recent FDA Approval of Afami-cel

Panelists discuss how the major unmet needs in treating synovial sarcoma include developing targeted therapies that effectively address the SS18::SSX fusion oncogene, improving early detection methods, and finding ways to overcome treatment resistance in metastatic disease.

Video content above is prompted by the following:

  • What are the biggest unmet needs in treating synovial sarcoma today?